The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differences in patient characteristics, treatment patterns, and clinical outcomes of renal cell carcinoma patients in public vs private health care systems in Brazil: Insights from the LACOG 1120 registry.
 
Pablo Barrios
No Relationships to Disclose
 
Sabina Aleixo
No Relationships to Disclose
 
Andrey Soares
Honoraria - Adium Pharma; Astellas Pharma; AstraZeneca; Bayer; BMS Brazil; Janssen; Merck Serono; MSD; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Adium Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Adium Pharma; Bayer; Ipsen; Janssen; Merck Serono; MSD
 
Diogo Bastos
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; MSD
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; MSD Oncology; MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen-Cilag
 
Adriano Silva
No Relationships to Disclose
 
Mariane Dias
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen; Merck; MSD Oncology; Zodiac Pharma
Consulting or Advisory Role - AstraZeneca; Ipsen; Janssen; Merck; MSD Oncology
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ipsen; Janssen Oncology; MSD Oncology; Zodiac Pharma
Research Funding - Bayer; BMS Brazil; Janssen Research & Development
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; MSD Oncology; Zodiac Pharma
 
Hyrlana Passos
No Relationships to Disclose
 
Karine Trindade
Honoraria - BMS Brazil; Janssen-Cilag; MSD Oncology
Consulting or Advisory Role - Astellas Pharma; Janssen-Cilag; MSD Oncology
Research Funding - BMS Brazil (Inst); Janssen-Cilag (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
 
Fernando Monteiro
Speakers' Bureau - Adium Pharma; BMS Brazil; MSD Oncology
Travel, Accommodations, Expenses - Adium Pharma; Ipsen; Merck Serono; MSD Oncology
Other Relationship - Brazilian Information in Oncology - BIO
 
Thiago Almeida
No Relationships to Disclose
 
Luis Carlos Antunes
No Relationships to Disclose
 
Cristina Sampaio
No Relationships to Disclose
 
Poliana Signorini
Speakers' Bureau - AstraZeneca; Lilly; Novartis
Travel, Accommodations, Expenses - AstraZeneca
 
Tercia Reis
No Relationships to Disclose
 
Bruno Santucci
No Relationships to Disclose
 
Ricardo Coelho
Honoraria - Astrazeneca; Bayer; Janssen; MSD
Consulting or Advisory Role - Janssen
Travel, Accommodations, Expenses - Janssen; MSD
 
Manuel Maia
No Relationships to Disclose
 
Tainá Cabalheiro
No Relationships to Disclose
 
Gustavo Gössling
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst)
 
Andre Fay
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Ipsen; Merck Sharp & Dohme; Novartis; Pfizer; Roche